Edition:
India

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.65USD
13 Dec 2017
Change (% chg)

$-0.01 (-1.68%)
Prev Close
$0.66
Open
$0.66
Day's High
$0.66
Day's Low
$0.61
Volume
54,460
Avg. Vol
81,763
52-wk High
$3.12
52-wk Low
$0.61

Select another date:

Mon, Dec 11 2017

BRIEF-Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc

* CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING Source text : [http://bit.ly/2kZxgLY] Further company coverage:

BRIEF-Neovasc announces qtrly loss per share $0.06

* Neovasc Inc - ‍Revenues decreased 55% to $1.4 million for three months ended September 30, 2017, compared to revenues of $3.0 million ​

BRIEF-Neovasc announces 65 million dollars offering of common shares and warrants

* NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS

BRIEF-Neovasc receives FDA approval to initiate pivotal reducer trial

* Neovasc receives FDA approval to initiate pivotal reducer trial

BRIEF-Neovasc provides litigation update

* Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co

BRIEF-Neovasc provides Tiara clinical update

* Neovasc Inc - ‍all cause, 30-day mortality in 33 patients who have reached 30 days post implant with Tiara is 12.1% (4/33) in Tiara trial​ Source text for Eikon: Further company coverage:

BRIEF-Neovasc reports Q2 loss per share $0.07

* Qtrly loss per share $0.07 Source text for Eikon: Further company coverage:

BRIEF-Neovasc says German Court partially found in favor of Edwards Lifesciences in its case against co

* District court in Munich has partially found in favour of Edwards Lifesciences Corporation in its case against Neovasc

Select another date: